Oligonucleotide-based drugs exhibit a wide range of mode of actions. They typically act on the RNA level, by steric hindrance or to recruit nuclease that will cleave the RNA strand. The ultimate goal is to correct the defect action of a target protein by inducing its degradation or right expression.